Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R)

  1. Calvo, X.
  2. Arenillas, L.
  3. Luño, E.
  4. Senent, L.
  5. Arnan, M.
  6. Ramos, F.
  7. Pedro, C.
  8. Tormo, M.
  9. Montoro, J.
  10. Díez-Campelo, M.
  11. Blanco, M.L.
  12. Arrizabalaga, B.
  13. Xicoy, B.
  14. Bonanad, S.
  15. Jerez, A.
  16. Nomdedeu, M.
  17. Ferrer, A.
  18. Sanz, G.F.
  19. Florensa, L.
Journal:
American Journal of Hematology

ISSN: 1096-8652 0361-8609

Year of publication: 2017

Volume: 92

Issue: 7

Pages: 614-621

Type: Article

DOI: 10.1002/AJH.24732 GOOGLE SCHOLAR lock_openOpen access editor